Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Abrahamsen

Showing results (91-100 of 211) with videos related to

Pageof 22
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 25, 2011
Esophageal and gastric cancer incidence and mortality in alendronate usersBo Abrahamsen, Michael Pazianas, Pia Eiken, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Risk of fracture in adults on renal replacement therapy: a Danish national cohort studyDitte Hansen, Jonas B Olesen, Gunnar H Gislason, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 10, 2012
Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription databaseMichael Pazianas, Emma M Clark, Pia A Eiken, et al.
Endocrine Reviews|September 1, 2018
Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical ManagementDennis M Black, Bo Abrahamsen, Mary L Bouxsein, et al.
Ugeskrift for Laeger|November 23, 2012
[Diagnosing and treating osteoporosis in patients with chronic obstructive pulmonary disease]Pia A Eiken, Dorte Brask-Lindemann, Jørgen Vestbo, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 21, 2018
A New Fracture Risk Assessment Tool (FREM) Based on Public Health RegistriesKatrine Hass Rubin, Sören Möller, Teresa Holmberg, et al.
Ugeskrift for Laeger|February 3, 2004
[Compliance with the treatment of osteoporosis with diphosphonates. A questionnaire among postmenopausal women]Rasmus Wulff, Bo Abrahamsen, Charlotte Albjerg Ejersted, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Excess Mortality in Treated and Untreated Hyperthyroidism Is Related to Cumulative Periods of Low Serum TSHMads Lillevang-Johansen, Bo Abrahamsen, Henrik Løvendahl Jørgensen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 18, 2013
Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic reviewKatrine Hass Rubin, Teresa Friis-Holmberg, Anne Pernille Hermann, et al.
Thyroid : Official Journal of the American Thyroid Association|January 17, 2019
Duration of Hyperthyroidism and Lack of Sufficient Treatment Are Associated with Increased Cardiovascular RiskMads Lillevang-Johansen, Bo Abrahamsen, Henrik Løvendahl Jørgensen, et al.
Pageof 22

Showing results (91-100 of 211) with videos related to

Sort By:
Pageof 22
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 25, 2011
Esophageal and gastric cancer incidence and mortality in alendronate usersBo Abrahamsen, Michael Pazianas, Pia Eiken, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Risk of fracture in adults on renal replacement therapy: a Danish national cohort studyDitte Hansen, Jonas B Olesen, Gunnar H Gislason, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 10, 2012
Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription databaseMichael Pazianas, Emma M Clark, Pia A Eiken, et al.
Endocrine Reviews|September 1, 2018
Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical ManagementDennis M Black, Bo Abrahamsen, Mary L Bouxsein, et al.
Ugeskrift for Laeger|November 23, 2012
[Diagnosing and treating osteoporosis in patients with chronic obstructive pulmonary disease]Pia A Eiken, Dorte Brask-Lindemann, Jørgen Vestbo, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 21, 2018
A New Fracture Risk Assessment Tool (FREM) Based on Public Health RegistriesKatrine Hass Rubin, Sören Möller, Teresa Holmberg, et al.
Ugeskrift for Laeger|February 3, 2004
[Compliance with the treatment of osteoporosis with diphosphonates. A questionnaire among postmenopausal women]Rasmus Wulff, Bo Abrahamsen, Charlotte Albjerg Ejersted, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Excess Mortality in Treated and Untreated Hyperthyroidism Is Related to Cumulative Periods of Low Serum TSHMads Lillevang-Johansen, Bo Abrahamsen, Henrik Løvendahl Jørgensen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 18, 2013
Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic reviewKatrine Hass Rubin, Teresa Friis-Holmberg, Anne Pernille Hermann, et al.
Thyroid : Official Journal of the American Thyroid Association|January 17, 2019
Duration of Hyperthyroidism and Lack of Sufficient Treatment Are Associated with Increased Cardiovascular RiskMads Lillevang-Johansen, Bo Abrahamsen, Henrik Løvendahl Jørgensen, et al.
Pageof 22